YIH
ONCY

Y-Intercept (HK)’s Oncolytics Biotech ONCY Stock Holding History

Y-Intercept (HK)’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.6K Buy
+13,290
New +$12.3K ﹤0.01% 1646

Other funds holding ONCY

EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
DA
Doliver Advisors Houston, Texas $442M AUM 34.09% 1-Year Est. Return
PAS
Professional Advisory Services Vero Beach, Florida $836M AUM 25.79% 1-Year Est. Return
CMA
Cedar Mountain Advisors Lake Oswego, Oregon $581M AUM 18.16% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
DWM
Dogwood Wealth Management Lenexa, Kansas $253M AUM 19.41% 1-Year Est. Return
WWM
Wolff Wiese Magana Carslbad, California $217M AUM 47.64% 1-Year Est. Return

Y-Intercept (HK)'s ONCY Position: Q2 2026 in Review

Y-Intercept (HK) opened a new position in Oncolytics Biotech (ONCY) in Q2 2026: 13,290 shares worth $12.6K. The stake represents ﹤0.01% of the portfolio and ranks #1646 among its holdings.

9 funds tracked by Wall St. Rank hold ONCY as of Q2 2026.

  • Y-Intercept (HK) held 13,290 shares of Oncolytics Biotech worth $12.6K as of Q2 2026.
  • Oncolytics Biotech was a new Y-Intercept (HK) position in Q2 2026.
  • Oncolytics Biotech made up ﹤0.01% of Y-Intercept (HK)'s portfolio in Q2 2026, its #1646 holding.
  • 9 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.